Google’s DeepMind turns first profit as revenues soar

The End of Silicon Valley as We Know It?

Pfizer and PostEra collab in $250M AI lab deal

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Biden's top science advisor working on AI Bill of Rights

Analyst reports trendsetting biotech breakthroughs

Tech analyst reports expansion for European tech

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

French AI strategy: Tech sector to receive over €2 bln in next 5 years